nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—Rosuvastatin—atherosclerosis	0.288	1	CrCtD
Pitavastatin—coronary artery disease—atherosclerosis	0.195	1	CtDrD
Pitavastatin—Fluvastatin—Rosuvastatin—atherosclerosis	0.157	1	CrCrCtD
Pitavastatin—HMGCR—atherosclerosis	0.0896	0.849	CbGaD
Pitavastatin—HMGCR—Rosuvastatin—atherosclerosis	0.0173	0.091	CbGbCtD
Pitavastatin—HMGCR—Simvastatin—atherosclerosis	0.0161	0.0846	CbGbCtD
Pitavastatin—ALB—atherosclerosis	0.0159	0.15	CbGaD
Pitavastatin—HMGCR—Lovastatin—atherosclerosis	0.0157	0.0828	CbGbCtD
Pitavastatin—HMGCR—Pravastatin—atherosclerosis	0.0157	0.0828	CbGbCtD
Pitavastatin—UGT1A3—Ezetimibe—atherosclerosis	0.0083	0.0437	CbGbCtD
Pitavastatin—SLCO2B1—Niacin—atherosclerosis	0.00816	0.043	CbGbCtD
Pitavastatin—UGT1A3—Simvastatin—atherosclerosis	0.00771	0.0407	CbGbCtD
Pitavastatin—UGT1A3—Lovastatin—atherosclerosis	0.00755	0.0398	CbGbCtD
Pitavastatin—SLCO2B1—Rosuvastatin—atherosclerosis	0.00694	0.0366	CbGbCtD
Pitavastatin—SLCO2B1—Pravastatin—atherosclerosis	0.00631	0.0333	CbGbCtD
Pitavastatin—SLCO1B3—Rosuvastatin—atherosclerosis	0.00616	0.0325	CbGbCtD
Pitavastatin—UGT2B7—Ezetimibe—atherosclerosis	0.006	0.0316	CbGbCtD
Pitavastatin—SLCO1B3—Pravastatin—atherosclerosis	0.00561	0.0296	CbGbCtD
Pitavastatin—UGT2B7—Simvastatin—atherosclerosis	0.00558	0.0294	CbGbCtD
Pitavastatin—UGT2B7—Lovastatin—atherosclerosis	0.00546	0.0288	CbGbCtD
Pitavastatin—SLCO1B1—Rosuvastatin—atherosclerosis	0.00359	0.0189	CbGbCtD
Pitavastatin—SLCO1B1—Ezetimibe—atherosclerosis	0.00359	0.0189	CbGbCtD
Pitavastatin—SLCO1B1—Simvastatin—atherosclerosis	0.00334	0.0176	CbGbCtD
Pitavastatin—SLCO1B1—Pravastatin—atherosclerosis	0.00327	0.0172	CbGbCtD
Pitavastatin—SLCO1B1—Lovastatin—atherosclerosis	0.00327	0.0172	CbGbCtD
Pitavastatin—ABCC2—Ezetimibe—atherosclerosis	0.00315	0.0166	CbGbCtD
Pitavastatin—ABCC2—Simvastatin—atherosclerosis	0.00293	0.0155	CbGbCtD
Pitavastatin—ABCC2—Pravastatin—atherosclerosis	0.00287	0.0151	CbGbCtD
Pitavastatin—ABCC2—Lovastatin—atherosclerosis	0.00287	0.0151	CbGbCtD
Pitavastatin—ABCG2—Ezetimibe—atherosclerosis	0.00285	0.015	CbGbCtD
Pitavastatin—ABCG2—Rosuvastatin—atherosclerosis	0.00285	0.015	CbGbCtD
Pitavastatin—ABCG2—Pravastatin—atherosclerosis	0.00259	0.0137	CbGbCtD
Pitavastatin—Immune-mediated necrotising myopathy—Rosuvastatin—atherosclerosis	0.00217	0.0498	CcSEcCtD
Pitavastatin—ALB—Rosuvastatin—atherosclerosis	0.00197	0.0104	CbGbCtD
Pitavastatin—Immune-mediated necrotising myopathy—Lovastatin—atherosclerosis	0.00184	0.0422	CcSEcCtD
Pitavastatin—Immune-mediated necrotising myopathy—Ezetimibe—atherosclerosis	0.0018	0.0414	CcSEcCtD
Pitavastatin—Myoglobin urine present—Rosuvastatin—atherosclerosis	0.00177	0.0407	CcSEcCtD
Pitavastatin—Myoglobinuria—Rosuvastatin—atherosclerosis	0.00177	0.0407	CcSEcCtD
Pitavastatin—Immune-mediated necrotising myopathy—Simvastatin—atherosclerosis	0.00172	0.0395	CcSEcCtD
Pitavastatin—Immune-mediated necrotising myopathy—Pravastatin—atherosclerosis	0.00155	0.0357	CcSEcCtD
Pitavastatin—CYP2C8—Simvastatin—atherosclerosis	0.00141	0.00745	CbGbCtD
Pitavastatin—CYP2C8—Lovastatin—atherosclerosis	0.00138	0.00729	CbGbCtD
Pitavastatin—CYP2C8—Pravastatin—atherosclerosis	0.00138	0.00729	CbGbCtD
Pitavastatin—Myoglobin urine present—Pravastatin—atherosclerosis	0.00127	0.0292	CcSEcCtD
Pitavastatin—Myoglobinuria—Pravastatin—atherosclerosis	0.00127	0.0292	CcSEcCtD
Pitavastatin—CYP2C9—Rosuvastatin—atherosclerosis	0.00106	0.00559	CbGbCtD
Pitavastatin—ABCB1—Ezetimibe—atherosclerosis	0.00103	0.00542	CbGbCtD
Pitavastatin—CYP2C9—Simvastatin—atherosclerosis	0.000985	0.00519	CbGbCtD
Pitavastatin—Forgetfulness—Rosuvastatin—atherosclerosis	0.000976	0.0224	CcSEcCtD
Pitavastatin—CYP2C9—Lovastatin—atherosclerosis	0.000964	0.00508	CbGbCtD
Pitavastatin—CYP2C9—Pravastatin—atherosclerosis	0.000964	0.00508	CbGbCtD
Pitavastatin—ABCB1—Simvastatin—atherosclerosis	0.000956	0.00504	CbGbCtD
Pitavastatin—ABCB1—Lovastatin—atherosclerosis	0.000935	0.00493	CbGbCtD
Pitavastatin—ABCB1—Pravastatin—atherosclerosis	0.000935	0.00493	CbGbCtD
Pitavastatin—Forgetfulness—Lovastatin—atherosclerosis	0.000827	0.019	CcSEcCtD
Pitavastatin—Forgetfulness—Ezetimibe—atherosclerosis	0.000811	0.0186	CcSEcCtD
Pitavastatin—Cognitive impairment—Rosuvastatin—atherosclerosis	0.000784	0.018	CcSEcCtD
Pitavastatin—Forgetfulness—Simvastatin—atherosclerosis	0.000774	0.0178	CcSEcCtD
Pitavastatin—Forgetfulness—Pravastatin—atherosclerosis	0.000699	0.0161	CcSEcCtD
Pitavastatin—Memory loss—Rosuvastatin—atherosclerosis	0.000696	0.016	CcSEcCtD
Pitavastatin—Cognitive impairment—Lovastatin—atherosclerosis	0.000664	0.0152	CcSEcCtD
Pitavastatin—Cognitive impairment—Ezetimibe—atherosclerosis	0.000651	0.0149	CcSEcCtD
Pitavastatin—Cognitive impairment—Simvastatin—atherosclerosis	0.000621	0.0143	CcSEcCtD
Pitavastatin—Memory loss—Lovastatin—atherosclerosis	0.00059	0.0135	CcSEcCtD
Pitavastatin—Memory loss—Ezetimibe—atherosclerosis	0.000578	0.0133	CcSEcCtD
Pitavastatin—Cognitive impairment—Pravastatin—atherosclerosis	0.000562	0.0129	CcSEcCtD
Pitavastatin—Memory loss—Simvastatin—atherosclerosis	0.000552	0.0127	CcSEcCtD
Pitavastatin—Memory loss—Pravastatin—atherosclerosis	0.000499	0.0114	CcSEcCtD
Pitavastatin—Cognitive disorder—Rosuvastatin—atherosclerosis	0.000473	0.0109	CcSEcCtD
Pitavastatin—Myositis—Rosuvastatin—atherosclerosis	0.000417	0.00957	CcSEcCtD
Pitavastatin—Cognitive disorder—Lovastatin—atherosclerosis	0.000401	0.0092	CcSEcCtD
Pitavastatin—Cognitive disorder—Ezetimibe—atherosclerosis	0.000393	0.00902	CcSEcCtD
Pitavastatin—Cognitive disorder—Simvastatin—atherosclerosis	0.000375	0.0086	CcSEcCtD
Pitavastatin—Cognitive disorder—Pravastatin—atherosclerosis	0.000339	0.00778	CcSEcCtD
Pitavastatin—Rosuvastatin—HMGCR—atherosclerosis	0.00032	0.293	CrCbGaD
Pitavastatin—Myopathy—Rosuvastatin—atherosclerosis	0.000292	0.00669	CcSEcCtD
Pitavastatin—Memory impairment—Rosuvastatin—atherosclerosis	0.000261	0.00598	CcSEcCtD
Pitavastatin—Fluvastatin—HMGCR—atherosclerosis	0.000258	0.237	CrCbGaD
Pitavastatin—Myopathy—Lovastatin—atherosclerosis	0.000247	0.00567	CcSEcCtD
Pitavastatin—Myopathy—Ezetimibe—atherosclerosis	0.000242	0.00556	CcSEcCtD
Pitavastatin—Interstitial lung disease—Ezetimibe—atherosclerosis	0.00024	0.00551	CcSEcCtD
Pitavastatin—Myopathy—Simvastatin—atherosclerosis	0.000231	0.00531	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.000231	0.0053	CcSEcCtD
Pitavastatin—Atorvastatin—AHR—atherosclerosis	0.000231	0.212	CrCbGaD
Pitavastatin—Interstitial lung disease—Simvastatin—atherosclerosis	0.000229	0.00526	CcSEcCtD
Pitavastatin—Atorvastatin—HMGCR—atherosclerosis	0.000225	0.206	CrCbGaD
Pitavastatin—Memory impairment—Lovastatin—atherosclerosis	0.000221	0.00507	CcSEcCtD
Pitavastatin—Memory impairment—Ezetimibe—atherosclerosis	0.000217	0.00497	CcSEcCtD
Pitavastatin—Myopathy—Niacin—atherosclerosis	0.000212	0.00487	CcSEcCtD
Pitavastatin—Myopathy—Pravastatin—atherosclerosis	0.000209	0.0048	CcSEcCtD
Pitavastatin—Interstitial lung disease—Pravastatin—atherosclerosis	0.000207	0.00475	CcSEcCtD
Pitavastatin—Memory impairment—Simvastatin—atherosclerosis	0.000207	0.00474	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Lovastatin—atherosclerosis	0.000196	0.0045	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.000192	0.00441	CcSEcCtD
Pitavastatin—Memory impairment—Pravastatin—atherosclerosis	0.000187	0.00429	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Simvastatin—atherosclerosis	0.000183	0.00421	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Niacin—atherosclerosis	0.000168	0.00386	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Pravastatin—atherosclerosis	0.000166	0.0038	CcSEcCtD
Pitavastatin—Hepatic failure—Rosuvastatin—atherosclerosis	0.000165	0.00379	CcSEcCtD
Pitavastatin—Renal failure acute—Rosuvastatin—atherosclerosis	0.000161	0.00369	CcSEcCtD
Pitavastatin—Amnesia—Rosuvastatin—atherosclerosis	0.000158	0.00363	CcSEcCtD
Pitavastatin—Hepatic failure—Lovastatin—atherosclerosis	0.00014	0.00321	CcSEcCtD
Pitavastatin—Hepatic failure—Ezetimibe—atherosclerosis	0.000137	0.00315	CcSEcCtD
Pitavastatin—Amnesia—Lovastatin—atherosclerosis	0.000134	0.00307	CcSEcCtD
Pitavastatin—Amnesia—Ezetimibe—atherosclerosis	0.000131	0.00301	CcSEcCtD
Pitavastatin—Hepatic failure—Simvastatin—atherosclerosis	0.000131	0.00301	CcSEcCtD
Pitavastatin—Influenza—Rosuvastatin—atherosclerosis	0.000128	0.00294	CcSEcCtD
Pitavastatin—Pain in extremity—Lovastatin—atherosclerosis	0.000126	0.00289	CcSEcCtD
Pitavastatin—Amnesia—Simvastatin—atherosclerosis	0.000125	0.00287	CcSEcCtD
Pitavastatin—Pain in extremity—Ezetimibe—atherosclerosis	0.000123	0.00283	CcSEcCtD
Pitavastatin—Hepatic failure—Pravastatin—atherosclerosis	0.000118	0.00272	CcSEcCtD
Pitavastatin—Renal failure acute—Pravastatin—atherosclerosis	0.000115	0.00264	CcSEcCtD
Pitavastatin—Amnesia—Pravastatin—atherosclerosis	0.000113	0.0026	CcSEcCtD
Pitavastatin—Jaundice—Rosuvastatin—atherosclerosis	0.000112	0.00256	CcSEcCtD
Pitavastatin—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00011	0.00253	CcSEcCtD
Pitavastatin—Influenza—Lovastatin—atherosclerosis	0.000109	0.0025	CcSEcCtD
Pitavastatin—Influenza—Ezetimibe—atherosclerosis	0.000107	0.00245	CcSEcCtD
Pitavastatin—Abdominal discomfort—Lovastatin—atherosclerosis	0.000104	0.00239	CcSEcCtD
Pitavastatin—Hepatitis—Rosuvastatin—atherosclerosis	0.000103	0.00236	CcSEcCtD
Pitavastatin—Erectile dysfunction—Lovastatin—atherosclerosis	0.0001	0.0023	CcSEcCtD
Pitavastatin—Erectile dysfunction—Ezetimibe—atherosclerosis	9.82e-05	0.00225	CcSEcCtD
Pitavastatin—Abdominal discomfort—Simvastatin—atherosclerosis	9.75e-05	0.00224	CcSEcCtD
Pitavastatin—Nasopharyngitis—Pravastatin—atherosclerosis	9.51e-05	0.00218	CcSEcCtD
Pitavastatin—Erectile dysfunction—Simvastatin—atherosclerosis	9.37e-05	0.00215	CcSEcCtD
Pitavastatin—Influenza—Niacin—atherosclerosis	9.34e-05	0.00214	CcSEcCtD
Pitavastatin—Jaundice—Ezetimibe—atherosclerosis	9.27e-05	0.00213	CcSEcCtD
Pitavastatin—Influenza—Pravastatin—atherosclerosis	9.2e-05	0.00211	CcSEcCtD
Pitavastatin—Jaundice—Simvastatin—atherosclerosis	8.84e-05	0.00203	CcSEcCtD
Pitavastatin—Hepatitis—Lovastatin—atherosclerosis	8.7e-05	0.002	CcSEcCtD
Pitavastatin—Erectile dysfunction—Niacin—atherosclerosis	8.6e-05	0.00197	CcSEcCtD
Pitavastatin—Hepatitis—Ezetimibe—atherosclerosis	8.54e-05	0.00196	CcSEcCtD
Pitavastatin—Erectile dysfunction—Pravastatin—atherosclerosis	8.47e-05	0.00194	CcSEcCtD
Pitavastatin—Hepatitis—Simvastatin—atherosclerosis	8.14e-05	0.00187	CcSEcCtD
Pitavastatin—Jaundice—Niacin—atherosclerosis	8.12e-05	0.00186	CcSEcCtD
Pitavastatin—Jaundice—Pravastatin—atherosclerosis	7.99e-05	0.00183	CcSEcCtD
Pitavastatin—Arthralgia—Rosuvastatin—atherosclerosis	7.61e-05	0.00175	CcSEcCtD
Pitavastatin—Myalgia—Rosuvastatin—atherosclerosis	7.61e-05	0.00175	CcSEcCtD
Pitavastatin—Hepatitis—Niacin—atherosclerosis	7.48e-05	0.00172	CcSEcCtD
Pitavastatin—Hypoaesthesia—Niacin—atherosclerosis	7.44e-05	0.00171	CcSEcCtD
Pitavastatin—Hepatitis—Pravastatin—atherosclerosis	7.36e-05	0.00169	CcSEcCtD
Pitavastatin—Confusional state—Rosuvastatin—atherosclerosis	7.36e-05	0.00169	CcSEcCtD
Pitavastatin—Back pain—Lovastatin—atherosclerosis	7.33e-05	0.00168	CcSEcCtD
Pitavastatin—Hypoaesthesia—Pravastatin—atherosclerosis	7.32e-05	0.00168	CcSEcCtD
Pitavastatin—Muscle spasms—Lovastatin—atherosclerosis	7.28e-05	0.00167	CcSEcCtD
Pitavastatin—Back pain—Ezetimibe—atherosclerosis	7.19e-05	0.00165	CcSEcCtD
Pitavastatin—Muscle spasms—Ezetimibe—atherosclerosis	7.15e-05	0.00164	CcSEcCtD
Pitavastatin—Ill-defined disorder—Lovastatin—atherosclerosis	7.03e-05	0.00161	CcSEcCtD
Pitavastatin—Ill-defined disorder—Ezetimibe—atherosclerosis	6.9e-05	0.00158	CcSEcCtD
Pitavastatin—Malaise—Lovastatin—atherosclerosis	6.83e-05	0.00157	CcSEcCtD
Pitavastatin—Muscle spasms—Simvastatin—atherosclerosis	6.81e-05	0.00156	CcSEcCtD
Pitavastatin—Malaise—Ezetimibe—atherosclerosis	6.7e-05	0.00154	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	6.65e-05	0.00153	CcSEcCtD
Pitavastatin—Insomnia—Rosuvastatin—atherosclerosis	6.6e-05	0.00151	CcSEcCtD
Pitavastatin—Ill-defined disorder—Simvastatin—atherosclerosis	6.58e-05	0.00151	CcSEcCtD
Pitavastatin—Myalgia—Lovastatin—atherosclerosis	6.45e-05	0.00148	CcSEcCtD
Pitavastatin—Arthralgia—Lovastatin—atherosclerosis	6.45e-05	0.00148	CcSEcCtD
Pitavastatin—Dyspepsia—Rosuvastatin—atherosclerosis	6.42e-05	0.00147	CcSEcCtD
Pitavastatin—Malaise—Simvastatin—atherosclerosis	6.39e-05	0.00147	CcSEcCtD
Pitavastatin—Discomfort—Lovastatin—atherosclerosis	6.37e-05	0.00146	CcSEcCtD
Pitavastatin—Arthralgia—Ezetimibe—atherosclerosis	6.33e-05	0.00145	CcSEcCtD
Pitavastatin—Myalgia—Ezetimibe—atherosclerosis	6.33e-05	0.00145	CcSEcCtD
Pitavastatin—Muscle spasms—Niacin—atherosclerosis	6.26e-05	0.00144	CcSEcCtD
Pitavastatin—Discomfort—Ezetimibe—atherosclerosis	6.25e-05	0.00143	CcSEcCtD
Pitavastatin—Constipation—Rosuvastatin—atherosclerosis	6.24e-05	0.00143	CcSEcCtD
Pitavastatin—Confusional state—Lovastatin—atherosclerosis	6.24e-05	0.00143	CcSEcCtD
Pitavastatin—Muscle spasms—Pravastatin—atherosclerosis	6.16e-05	0.00141	CcSEcCtD
Pitavastatin—Confusional state—Ezetimibe—atherosclerosis	6.12e-05	0.0014	CcSEcCtD
Pitavastatin—Arthralgia—Simvastatin—atherosclerosis	6.03e-05	0.00138	CcSEcCtD
Pitavastatin—Myalgia—Simvastatin—atherosclerosis	6.03e-05	0.00138	CcSEcCtD
Pitavastatin—Feeling abnormal—Rosuvastatin—atherosclerosis	6.01e-05	0.00138	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	5.97e-05	0.00137	CcSEcCtD
Pitavastatin—Discomfort—Simvastatin—atherosclerosis	5.96e-05	0.00137	CcSEcCtD
Pitavastatin—Ill-defined disorder—Pravastatin—atherosclerosis	5.95e-05	0.00136	CcSEcCtD
Pitavastatin—Confusional state—Simvastatin—atherosclerosis	5.83e-05	0.00134	CcSEcCtD
Pitavastatin—Urticaria—Rosuvastatin—atherosclerosis	5.8e-05	0.00133	CcSEcCtD
Pitavastatin—Malaise—Pravastatin—atherosclerosis	5.78e-05	0.00133	CcSEcCtD
Pitavastatin—Abdominal pain—Rosuvastatin—atherosclerosis	5.77e-05	0.00132	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—atherosclerosis	5.66e-05	0.0519	CrCbGaD
Pitavastatin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	5.63e-05	0.00129	CcSEcCtD
Pitavastatin—Insomnia—Lovastatin—atherosclerosis	5.59e-05	0.00128	CcSEcCtD
Pitavastatin—Arthralgia—Niacin—atherosclerosis	5.54e-05	0.00127	CcSEcCtD
Pitavastatin—Myalgia—Niacin—atherosclerosis	5.54e-05	0.00127	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	5.53e-05	0.00127	CcSEcCtD
Pitavastatin—Insomnia—Ezetimibe—atherosclerosis	5.49e-05	0.00126	CcSEcCtD
Pitavastatin—Arthralgia—Pravastatin—atherosclerosis	5.46e-05	0.00125	CcSEcCtD
Pitavastatin—Myalgia—Pravastatin—atherosclerosis	5.46e-05	0.00125	CcSEcCtD
Pitavastatin—Dyspepsia—Lovastatin—atherosclerosis	5.44e-05	0.00125	CcSEcCtD
Pitavastatin—Discomfort—Pravastatin—atherosclerosis	5.39e-05	0.00124	CcSEcCtD
Pitavastatin—Hypersensitivity—Rosuvastatin—atherosclerosis	5.38e-05	0.00123	CcSEcCtD
Pitavastatin—Dyspepsia—Ezetimibe—atherosclerosis	5.34e-05	0.00123	CcSEcCtD
Pitavastatin—Fatigue—Lovastatin—atherosclerosis	5.33e-05	0.00122	CcSEcCtD
Pitavastatin—Constipation—Lovastatin—atherosclerosis	5.29e-05	0.00121	CcSEcCtD
Pitavastatin—Confusional state—Pravastatin—atherosclerosis	5.27e-05	0.00121	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	5.27e-05	0.00121	CcSEcCtD
Pitavastatin—Asthenia—Rosuvastatin—atherosclerosis	5.24e-05	0.0012	CcSEcCtD
Pitavastatin—Insomnia—Simvastatin—atherosclerosis	5.23e-05	0.0012	CcSEcCtD
Pitavastatin—Fatigue—Ezetimibe—atherosclerosis	5.23e-05	0.0012	CcSEcCtD
Pitavastatin—Constipation—Ezetimibe—atherosclerosis	5.19e-05	0.00119	CcSEcCtD
Pitavastatin—Pruritus—Rosuvastatin—atherosclerosis	5.16e-05	0.00118	CcSEcCtD
Pitavastatin—Feeling abnormal—Lovastatin—atherosclerosis	5.1e-05	0.00117	CcSEcCtD
Pitavastatin—Dyspepsia—Simvastatin—atherosclerosis	5.09e-05	0.00117	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Lovastatin—atherosclerosis	5.06e-05	0.00116	CcSEcCtD
Pitavastatin—Feeling abnormal—Ezetimibe—atherosclerosis	5e-05	0.00115	CcSEcCtD
Pitavastatin—Diarrhoea—Rosuvastatin—atherosclerosis	4.99e-05	0.00115	CcSEcCtD
Pitavastatin—Fatigue—Simvastatin—atherosclerosis	4.99e-05	0.00114	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Ezetimibe—atherosclerosis	4.96e-05	0.00114	CcSEcCtD
Pitavastatin—Constipation—Simvastatin—atherosclerosis	4.95e-05	0.00114	CcSEcCtD
Pitavastatin—Urticaria—Lovastatin—atherosclerosis	4.91e-05	0.00113	CcSEcCtD
Pitavastatin—Abdominal pain—Lovastatin—atherosclerosis	4.89e-05	0.00112	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Niacin—atherosclerosis	4.84e-05	0.00111	CcSEcCtD
Pitavastatin—Dizziness—Rosuvastatin—atherosclerosis	4.83e-05	0.00111	CcSEcCtD
Pitavastatin—Urticaria—Ezetimibe—atherosclerosis	4.82e-05	0.00111	CcSEcCtD
Pitavastatin—Insomnia—Niacin—atherosclerosis	4.8e-05	0.0011	CcSEcCtD
Pitavastatin—Abdominal pain—Ezetimibe—atherosclerosis	4.79e-05	0.0011	CcSEcCtD
Pitavastatin—Feeling abnormal—Simvastatin—atherosclerosis	4.77e-05	0.00109	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	4.76e-05	0.00109	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Simvastatin—atherosclerosis	4.73e-05	0.00109	CcSEcCtD
Pitavastatin—Insomnia—Pravastatin—atherosclerosis	4.73e-05	0.00109	CcSEcCtD
Pitavastatin—Dyspepsia—Niacin—atherosclerosis	4.68e-05	0.00107	CcSEcCtD
Pitavastatin—Dyspepsia—Pravastatin—atherosclerosis	4.6e-05	0.00106	CcSEcCtD
Pitavastatin—Rash—Rosuvastatin—atherosclerosis	4.6e-05	0.00106	CcSEcCtD
Pitavastatin—Dermatitis—Rosuvastatin—atherosclerosis	4.6e-05	0.00105	CcSEcCtD
Pitavastatin—Urticaria—Simvastatin—atherosclerosis	4.6e-05	0.00105	CcSEcCtD
Pitavastatin—Abdominal pain—Simvastatin—atherosclerosis	4.57e-05	0.00105	CcSEcCtD
Pitavastatin—Headache—Rosuvastatin—atherosclerosis	4.57e-05	0.00105	CcSEcCtD
Pitavastatin—Hypersensitivity—Lovastatin—atherosclerosis	4.56e-05	0.00105	CcSEcCtD
Pitavastatin—Fatigue—Pravastatin—atherosclerosis	4.51e-05	0.00103	CcSEcCtD
Pitavastatin—Constipation—Pravastatin—atherosclerosis	4.47e-05	0.00103	CcSEcCtD
Pitavastatin—Hypersensitivity—Ezetimibe—atherosclerosis	4.47e-05	0.00103	CcSEcCtD
Pitavastatin—Asthenia—Lovastatin—atherosclerosis	4.44e-05	0.00102	CcSEcCtD
Pitavastatin—Pruritus—Lovastatin—atherosclerosis	4.38e-05	0.001	CcSEcCtD
Pitavastatin—Asthenia—Ezetimibe—atherosclerosis	4.35e-05	0.000999	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Niacin—atherosclerosis	4.34e-05	0.000997	CcSEcCtD
Pitavastatin—Nausea—Rosuvastatin—atherosclerosis	4.33e-05	0.000995	CcSEcCtD
Pitavastatin—Feeling abnormal—Pravastatin—atherosclerosis	4.31e-05	0.000989	CcSEcCtD
Pitavastatin—Pruritus—Ezetimibe—atherosclerosis	4.29e-05	0.000985	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Pravastatin—atherosclerosis	4.28e-05	0.000981	CcSEcCtD
Pitavastatin—Hypersensitivity—Simvastatin—atherosclerosis	4.26e-05	0.000978	CcSEcCtD
Pitavastatin—Diarrhoea—Lovastatin—atherosclerosis	4.23e-05	0.000971	CcSEcCtD
Pitavastatin—Urticaria—Niacin—atherosclerosis	4.22e-05	0.000968	CcSEcCtD
Pitavastatin—Abdominal pain—Niacin—atherosclerosis	4.2e-05	0.000964	CcSEcCtD
Pitavastatin—Urticaria—Pravastatin—atherosclerosis	4.15e-05	0.000953	CcSEcCtD
Pitavastatin—Asthenia—Simvastatin—atherosclerosis	4.15e-05	0.000952	CcSEcCtD
Pitavastatin—Diarrhoea—Ezetimibe—atherosclerosis	4.15e-05	0.000952	CcSEcCtD
Pitavastatin—Abdominal pain—Pravastatin—atherosclerosis	4.13e-05	0.000949	CcSEcCtD
Pitavastatin—Pruritus—Simvastatin—atherosclerosis	4.09e-05	0.000939	CcSEcCtD
Pitavastatin—Dizziness—Lovastatin—atherosclerosis	4.09e-05	0.000938	CcSEcCtD
Pitavastatin—Dizziness—Ezetimibe—atherosclerosis	4.01e-05	0.000921	CcSEcCtD
Pitavastatin—Diarrhoea—Simvastatin—atherosclerosis	3.96e-05	0.000908	CcSEcCtD
Pitavastatin—Hypersensitivity—Niacin—atherosclerosis	3.91e-05	0.000898	CcSEcCtD
Pitavastatin—Rash—Lovastatin—atherosclerosis	3.9e-05	0.000895	CcSEcCtD
Pitavastatin—Dermatitis—Lovastatin—atherosclerosis	3.9e-05	0.000894	CcSEcCtD
Pitavastatin—Headache—Lovastatin—atherosclerosis	3.87e-05	0.000889	CcSEcCtD
Pitavastatin—Hypersensitivity—Pravastatin—atherosclerosis	3.85e-05	0.000884	CcSEcCtD
Pitavastatin—Dizziness—Simvastatin—atherosclerosis	3.83e-05	0.000878	CcSEcCtD
Pitavastatin—Rash—Ezetimibe—atherosclerosis	3.82e-05	0.000878	CcSEcCtD
Pitavastatin—Dermatitis—Ezetimibe—atherosclerosis	3.82e-05	0.000877	CcSEcCtD
Pitavastatin—Asthenia—Niacin—atherosclerosis	3.81e-05	0.000875	CcSEcCtD
Pitavastatin—Headache—Ezetimibe—atherosclerosis	3.8e-05	0.000872	CcSEcCtD
Pitavastatin—Pruritus—Niacin—atherosclerosis	3.76e-05	0.000862	CcSEcCtD
Pitavastatin—Asthenia—Pravastatin—atherosclerosis	3.75e-05	0.000861	CcSEcCtD
Pitavastatin—Pruritus—Pravastatin—atherosclerosis	3.7e-05	0.000849	CcSEcCtD
Pitavastatin—Nausea—Lovastatin—atherosclerosis	3.67e-05	0.000843	CcSEcCtD
Pitavastatin—Rash—Simvastatin—atherosclerosis	3.65e-05	0.000837	CcSEcCtD
Pitavastatin—Dermatitis—Simvastatin—atherosclerosis	3.64e-05	0.000836	CcSEcCtD
Pitavastatin—Diarrhoea—Niacin—atherosclerosis	3.63e-05	0.000834	CcSEcCtD
Pitavastatin—Headache—Simvastatin—atherosclerosis	3.62e-05	0.000832	CcSEcCtD
Pitavastatin—Nausea—Ezetimibe—atherosclerosis	3.6e-05	0.000827	CcSEcCtD
Pitavastatin—Diarrhoea—Pravastatin—atherosclerosis	3.58e-05	0.000821	CcSEcCtD
Pitavastatin—Dizziness—Niacin—atherosclerosis	3.51e-05	0.000806	CcSEcCtD
Pitavastatin—Dizziness—Pravastatin—atherosclerosis	3.46e-05	0.000794	CcSEcCtD
Pitavastatin—Nausea—Simvastatin—atherosclerosis	3.44e-05	0.000789	CcSEcCtD
Pitavastatin—Rash—Niacin—atherosclerosis	3.35e-05	0.000769	CcSEcCtD
Pitavastatin—Dermatitis—Niacin—atherosclerosis	3.35e-05	0.000768	CcSEcCtD
Pitavastatin—Headache—Niacin—atherosclerosis	3.33e-05	0.000764	CcSEcCtD
Pitavastatin—Rash—Pravastatin—atherosclerosis	3.3e-05	0.000757	CcSEcCtD
Pitavastatin—Dermatitis—Pravastatin—atherosclerosis	3.29e-05	0.000756	CcSEcCtD
Pitavastatin—Headache—Pravastatin—atherosclerosis	3.28e-05	0.000752	CcSEcCtD
Pitavastatin—Nausea—Niacin—atherosclerosis	3.15e-05	0.000724	CcSEcCtD
Pitavastatin—Nausea—Pravastatin—atherosclerosis	3.11e-05	0.000713	CcSEcCtD
Pitavastatin—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.83e-06	8.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BGN—atherosclerosis	1.83e-06	8.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.83e-06	8.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOA5—atherosclerosis	1.82e-06	8.47e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.82e-06	8.46e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.82e-06	8.45e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—INS—atherosclerosis	1.81e-06	8.43e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOA5—atherosclerosis	1.81e-06	8.42e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	1.81e-06	8.39e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APOE—atherosclerosis	1.81e-06	8.39e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.8e-06	8.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.79e-06	8.33e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CAV1—atherosclerosis	1.79e-06	8.31e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—F2—atherosclerosis	1.79e-06	8.3e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—atherosclerosis	1.78e-06	8.3e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APOA1—atherosclerosis	1.78e-06	8.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.77e-06	8.23e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS2—atherosclerosis	1.77e-06	8.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.76e-06	8.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.76e-06	8.18e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.75e-06	8.15e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HMOX1—atherosclerosis	1.75e-06	8.15e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PLA2G1B—atherosclerosis	1.74e-06	8.11e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—atherosclerosis	1.74e-06	8.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.74e-06	8.07e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOA2—atherosclerosis	1.74e-06	8.07e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.74e-06	8.07e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALOX15—atherosclerosis	1.74e-06	8.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.73e-06	8.06e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.73e-06	8.03e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.72e-06	8.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.72e-06	7.99e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCG5—atherosclerosis	1.71e-06	7.97e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.71e-06	7.97e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.71e-06	7.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CG—atherosclerosis	1.71e-06	7.95e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—INS—atherosclerosis	1.71e-06	7.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.71e-06	7.94e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.71e-06	7.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.69e-06	7.88e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALOX5—atherosclerosis	1.68e-06	7.83e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.68e-06	7.83e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOB—atherosclerosis	1.68e-06	7.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.67e-06	7.78e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—atherosclerosis	1.66e-06	7.73e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LPA—atherosclerosis	1.66e-06	7.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.64e-06	7.64e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—atherosclerosis	1.63e-06	7.59e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—atherosclerosis	1.63e-06	7.57e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HMOX1—atherosclerosis	1.62e-06	7.55e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.62e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.62e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.62e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOA2—atherosclerosis	1.62e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.62e-06	7.54e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BGN—atherosclerosis	1.6e-06	7.46e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—LPL—atherosclerosis	1.6e-06	7.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.6e-06	7.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.6e-06	7.44e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NOS3—atherosclerosis	1.59e-06	7.39e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOA5—atherosclerosis	1.59e-06	7.38e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—atherosclerosis	1.57e-06	7.31e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—atherosclerosis	1.57e-06	7.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.57e-06	7.28e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF1—atherosclerosis	1.57e-06	7.28e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GPX1—atherosclerosis	1.56e-06	7.27e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.56e-06	7.24e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOB—atherosclerosis	1.56e-06	7.23e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LPA—atherosclerosis	1.55e-06	7.19e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—INS—atherosclerosis	1.54e-06	7.17e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.53e-06	7.1e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CD36—atherosclerosis	1.52e-06	7.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.52e-06	7.06e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.51e-06	7.04e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—atherosclerosis	1.51e-06	7.03e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NAMPT—atherosclerosis	1.51e-06	7.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.51e-06	7.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LIPC—atherosclerosis	1.51e-06	7.02e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.5e-06	6.98e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LIPC—atherosclerosis	1.5e-06	6.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOC3—atherosclerosis	1.5e-06	6.98e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NOS3—atherosclerosis	1.5e-06	6.97e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BGN—atherosclerosis	1.5e-06	6.97e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOC3—atherosclerosis	1.49e-06	6.94e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LDLR—atherosclerosis	1.49e-06	6.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.49e-06	6.92e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINE1—atherosclerosis	1.49e-06	6.91e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—LPL—atherosclerosis	1.49e-06	6.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOA5—atherosclerosis	1.48e-06	6.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LDLR—atherosclerosis	1.48e-06	6.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALOX5—atherosclerosis	1.48e-06	6.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CETP—atherosclerosis	1.46e-06	6.77e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—atherosclerosis	1.45e-06	6.76e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPX1—atherosclerosis	1.45e-06	6.73e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CETP—atherosclerosis	1.45e-06	6.73e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—atherosclerosis	1.44e-06	6.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.44e-06	6.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.43e-06	6.64e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.42e-06	6.6e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS3—atherosclerosis	1.42e-06	6.6e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARA—atherosclerosis	1.42e-06	6.59e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—atherosclerosis	1.41e-06	6.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.41e-06	6.56e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CD36—atherosclerosis	1.41e-06	6.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.4e-06	6.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.4e-06	6.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.4e-06	6.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SCARB1—atherosclerosis	1.39e-06	6.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.38e-06	6.41e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AGT—atherosclerosis	1.37e-06	6.38e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—atherosclerosis	1.37e-06	6.37e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.36e-06	6.31e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NOS3—atherosclerosis	1.35e-06	6.29e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOE—atherosclerosis	1.34e-06	6.25e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—atherosclerosis	1.34e-06	6.22e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CAV1—atherosclerosis	1.33e-06	6.19e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOA1—atherosclerosis	1.33e-06	6.18e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAMPT—atherosclerosis	1.32e-06	6.15e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.32e-06	6.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LIPC—atherosclerosis	1.32e-06	6.12e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARA—atherosclerosis	1.31e-06	6.1e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMGCR—atherosclerosis	1.31e-06	6.09e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOC3—atherosclerosis	1.31e-06	6.08e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LDLR—atherosclerosis	1.3e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.27e-06	5.92e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AGT—atherosclerosis	1.27e-06	5.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CETP—atherosclerosis	1.27e-06	5.9e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.27e-06	5.88e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.25e-06	5.79e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOE—atherosclerosis	1.24e-06	5.79e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—atherosclerosis	1.24e-06	5.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.24e-06	5.75e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CAV1—atherosclerosis	1.23e-06	5.73e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOA1—atherosclerosis	1.23e-06	5.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.23e-06	5.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LIPC—atherosclerosis	1.23e-06	5.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOC3—atherosclerosis	1.22e-06	5.68e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SCARB1—atherosclerosis	1.22e-06	5.65e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LDLR—atherosclerosis	1.21e-06	5.64e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	1.21e-06	5.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.19e-06	5.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CETP—atherosclerosis	1.19e-06	5.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.18e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.17e-06	5.46e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—atherosclerosis	1.17e-06	5.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCA1—atherosclerosis	1.17e-06	5.43e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—INS—atherosclerosis	1.15e-06	5.34e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMGCR—atherosclerosis	1.15e-06	5.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.14e-06	5.28e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.13e-06	5.23e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.12e-06	5.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.11e-06	5.14e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—atherosclerosis	1.1e-06	5.11e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—atherosclerosis	1.08e-06	5.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.07e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—INS—atherosclerosis	1.06e-06	4.94e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—atherosclerosis	1.05e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCA1—atherosclerosis	1.02e-06	4.76e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—atherosclerosis	1.02e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.01e-06	4.68e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NOS3—atherosclerosis	1.01e-06	4.68e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMOX1—atherosclerosis	1e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—atherosclerosis	9.75e-07	4.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.67e-07	4.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—atherosclerosis	9.67e-07	4.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOB—atherosclerosis	9.65e-07	4.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOB—atherosclerosis	9.6e-07	4.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCA1—atherosclerosis	9.56e-07	4.44e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—atherosclerosis	9.39e-07	4.36e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—atherosclerosis	9.39e-07	4.36e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—atherosclerosis	9.34e-07	4.34e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NOS3—atherosclerosis	9.33e-07	4.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LPL—atherosclerosis	9.22e-07	4.28e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—atherosclerosis	9.21e-07	4.28e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LPL—atherosclerosis	9.16e-07	4.26e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPX1—atherosclerosis	8.99e-07	4.18e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—atherosclerosis	8.97e-07	4.17e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPX1—atherosclerosis	8.94e-07	4.16e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMOX1—atherosclerosis	8.78e-07	4.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CD36—atherosclerosis	8.76e-07	4.07e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CD36—atherosclerosis	8.71e-07	4.05e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—atherosclerosis	8.53e-07	3.96e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOB—atherosclerosis	8.41e-07	3.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—atherosclerosis	8.3e-07	3.86e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—atherosclerosis	8.25e-07	3.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.2e-07	3.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—atherosclerosis	8.18e-07	3.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARA—atherosclerosis	8.14e-07	3.78e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARA—atherosclerosis	8.09e-07	3.76e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LPL—atherosclerosis	8.03e-07	3.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AGT—atherosclerosis	7.88e-07	3.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOB—atherosclerosis	7.86e-07	3.65e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AGT—atherosclerosis	7.84e-07	3.64e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPX1—atherosclerosis	7.83e-07	3.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOE—atherosclerosis	7.73e-07	3.59e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOE—atherosclerosis	7.68e-07	3.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CAV1—atherosclerosis	7.65e-07	3.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.64e-07	3.55e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOA1—atherosclerosis	7.64e-07	3.55e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CD36—atherosclerosis	7.63e-07	3.55e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CAV1—atherosclerosis	7.61e-07	3.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOA1—atherosclerosis	7.59e-07	3.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LPL—atherosclerosis	7.5e-07	3.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPX1—atherosclerosis	7.32e-07	3.4e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—atherosclerosis	7.31e-07	3.4e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—atherosclerosis	7.23e-07	3.36e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CD36—atherosclerosis	7.13e-07	3.31e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARA—atherosclerosis	7.09e-07	3.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.97e-07	3.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—atherosclerosis	6.93e-07	3.22e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—atherosclerosis	6.89e-07	3.2e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AGT—atherosclerosis	6.87e-07	3.19e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.75e-07	3.14e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOE—atherosclerosis	6.73e-07	3.13e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—atherosclerosis	6.73e-07	3.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—atherosclerosis	6.69e-07	3.11e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CAV1—atherosclerosis	6.67e-07	3.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOA1—atherosclerosis	6.65e-07	3.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARA—atherosclerosis	6.63e-07	3.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—INS—atherosclerosis	6.6e-07	3.07e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—INS—atherosclerosis	6.56e-07	3.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—atherosclerosis	6.52e-07	3.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AGT—atherosclerosis	6.42e-07	2.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOE—atherosclerosis	6.29e-07	2.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CAV1—atherosclerosis	6.23e-07	2.9e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—atherosclerosis	6.22e-07	2.89e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOA1—atherosclerosis	6.22e-07	2.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.07e-07	2.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—atherosclerosis	6.05e-07	2.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—atherosclerosis	5.86e-07	2.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NOS3—atherosclerosis	5.79e-07	2.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NOS3—atherosclerosis	5.75e-07	2.67e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—INS—atherosclerosis	5.75e-07	2.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.67e-07	2.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—atherosclerosis	5.48e-07	2.55e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—INS—atherosclerosis	5.37e-07	2.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—atherosclerosis	5.29e-07	2.46e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—atherosclerosis	5.27e-07	2.45e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—atherosclerosis	5.26e-07	2.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NOS3—atherosclerosis	5.04e-07	2.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—atherosclerosis	4.92e-07	2.29e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NOS3—atherosclerosis	4.71e-07	2.19e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—atherosclerosis	4.63e-07	2.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—atherosclerosis	4.61e-07	2.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.31e-07	2e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—atherosclerosis	4.29e-07	1.99e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—atherosclerosis	2.66e-07	1.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—atherosclerosis	2.65e-07	1.23e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—atherosclerosis	2.32e-07	1.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—atherosclerosis	2.17e-07	1.01e-05	CbGpPWpGaD
